| Literature DB >> 28928690 |
Shelly R Cooper1, Corentin Gonthier2, Deanna M Barch1, Todd S Braver1.
Abstract
Investigating individual differences in cognition requires addressing questions not often thought about in standard experimental designs, especially regarding the psychometric properties of the task. Using the AX-CPT cognitive control task as a case study example, we address four concerns that one may encounter when researching the topic of individual differences in cognition. First, we demonstrate the importance of variability in task scores, which in turn directly impacts reliability, particularly when comparing correlations in different populations. Second, we demonstrate the importance of variability and reliability for evaluating potential failures to replicate predicted correlations, even within the same population. Third, we demonstrate how researchers can turn to evaluating psychometric properties as a way of evaluating the feasibility of utilizing the task in new settings (e.g., online administration). Lastly, we show how the examination of psychometric properties can help researchers make informed decisions when designing a study, such as determining the appropriate number of trials for a task.Entities:
Keywords: AX-CPT; psychometrics; reliability; replication; task design; variability
Year: 2017 PMID: 28928690 PMCID: PMC5591582 DOI: 10.3389/fpsyg.2017.01482
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Correlations between the AX-CPT and the RISE as a function of population.
| RISE condition | AX-CPT trial type | ||||||
|---|---|---|---|---|---|---|---|
| Associative recognition | AX | 0.18 | 0.25 | -0.47 | 0.318 | 0.76 | 0.85 |
| AY | 0.00 | 0.21 | -1.46 | 0.072+ | 0.71 | 0.84 | |
| BX | 0.25 | 0.26 | -0.04 | 0.486 | 0.76 | 0.79 | |
| BY | 0.06 | 0.23 | -1.17 | 0.121 | 0.72 | 0.80 | |
| Item recognition Associative encoding | AX | 0.27 | 0.41 | -1.06 | 0.144 | 0.76 | 0.85 |
| AY | 0.15 | 0.32 | -1.26 | 0.103+ | 0.71 | 0.85 | |
| BX | 0.18 | 0.40 | -1.70 | 0.044∗ | 0.76 | 0.80 | |
| BY | 0.09 | 0.37 | -2.12 | 0.017∗ | 0.72 | 0.80 | |
| Item recognition Item encoding | AX | 0.30 | 0.49 | -1.54 | 0.062+ | 0.78 | 0.87 |
| AY | 0.13 | 0.33 | -1.51 | 0.066+ | 0.73 | 0.86 | |
| BX | 0.17 | 0.44 | -2.08 | 0.019∗ | 0.78 | 0.81 | |
| BY | 0.07 | 0.39 | -2.39 | 0.008∗ | 0.74 | 0.82 | |
Descriptive statistics of AX-CPT accuracy: Issue 1.
| Group | N subjects (% female) | Mean age (range) | Trial type | Mean accuracy | Variance × 10-4 | Min | Max |
|---|---|---|---|---|---|---|---|
| CTRL | 119 (49.6%) | 38.88 (18–65) | AX | 0.97 | 8.42 | 0.86 | 1.00 |
| AY | 0.94 | 40.11 | 0.69 | 1.00 | |||
| BX | 0.91 | 108.35 | 0.40 | 1.00 | |||
| BY | 0.98 | 14.42 | 0.75 | 1.00 | |||
| SCZ | 92 (41.3%) | 39.79 (18–59) | AX | 0.92 | 91.78 | 0.41 | 1.00 |
| AY | 0.88 | 211.16 | 0.33 | 1.00 | |||
| BX | 0.84 | 217.33 | 0.27 | 1.00 | |||
| BY | 0.95 | 79.77 | 0.29 | 1.00 | |||
Internal consistency and test–retest reliability estimates: Issue 1.
| Group | Trial type | T1 α | T2 α | T3 α | T1–T2–T3 ICC |
|---|---|---|---|---|---|
| CTRL | AX | 0.82 | 0.78 | 0.81 | |
| AY | 0.43 | 0.47 | 0.68 | ||
| BX | 0.79 | 0.65 | 0.73 | ||
| BY | 0.14 | 0.21 | 0.32 | ||
| SCZ | AX | 0.95 | 0.93 | 0.95 | |
| AY | 0.77 | 0.80 | 0.80 | ||
| BX | 0.72 | 0.81 | 0.81 | ||
| BY | 0.50 | 0.55 | 0.67 | ||
Descriptive statistics of AX-CPT accuracy and internal consistency reliability estimates: Issue 2.
| Group | N subjects (% female) | Mean age (range) | Trial type | Mean accuracy | Variance × 10-4 | Min | Max | α |
|---|---|---|---|---|---|---|---|---|
| Savoy | 93 (78.5%) | 20.18 (17–25) | AX | 0.96 | 25.43 | 0.72 | 1.00 | 0.60 |
| AY | 0.90 | 141.26 | 0.50 | 1.00 | 0.39 | |||
| BX | 0.94 | 80.50 | 0.60 | 1.00 | 0.31 | |||
| BY | 0.99 | 3.14 | 0.93 | 1.00 | 0.22 | |||
| Temple | 104 (73.4%) | 21.33 (18–25) | AX | 0.86 | 171.01 | 0.38 | 1.00 | 0.90 |
| AY | 0.90 | 94.53 | 0.57 | 1.00 | 0.36 | |||
| BX | 0.88 | 265.96 | 0.21 | 1.00 | 0.77 | |||
| BY | 0.98 | 13.27 | 0.74 | 1.00 | 0.79 | |||
Descriptive statistics of AX-CPT accuracy and internal consistency reliability estimates: Issue 3.
| Group | N subjects (% female) | Mean age (range) | Trial type | Mean accuracy | Variance × 10-4 | Min | Max | α |
|---|---|---|---|---|---|---|---|---|
| In-lab | 93 (78.5%) | 20.18 (17–25) | AX | 0.94 | 52.66 | 0.57 | 1.00 | 0.74 |
| AY | 0.92 | 82.89 | 0.70 | 1.00 | 0.15 | |||
| BX | 0.80 | 250.98 | 0.30 | 1.00 | 0.39 | |||
| BY | 0.99 | 4.56 | 0.90 | 1.00 | 0.29 | |||
| MTurk | 65 (47.7%) | 33.90 (21–53) | AX | 0.93 | 84.79 | 0.45 | 1.00 | 0.82 |
| AY | 0.93 | 92.21 | 0.60 | 1.00 | 0.29 | |||
| BX | 0.83 | 200.87 | 0.40 | 1.00 | 0.35 | |||
| BY | 0.98 | 10.05 | 0.82 | 1.00 | 0.62 | |||
Descriptive statistics of AX-CPT accuracy: Issue 4.
| Trial type | Blocks included | Trials per block | Mean accuracy | Variance × 10-4 | Min | Max |
|---|---|---|---|---|---|---|
| AX | Block 1 | 24 | 0.94 | 63.32 | 0.52 | 1.00 |
| Blocks 1 & 2 | 48 | 0.92 | 66.40 | 0.67 | 1.00 | |
| Blocks 1 & 2 & 3 | 72 | 0.92 | 76.03 | 0.58 | 1.00 | |
| AY | Block 1 | 6 | 0.93 | 70.51 | 0.67 | 1.00 |
| Blocks 1 & 2 | 12 | 0.93 | 65.52 | 0.62 | 1.00 | |
| Blocks 1 & 2 & 3 | 18 | 0.92 | 66.80 | 0.58 | 1.00 | |
| BX | Block 1 | 6 | 0.85 | 194.38 | 0.50 | 1.00 |
| Blocks 1 & 2 | 12 | 0.86 | 124.26 | 0.58 | 1.00 | |
| Blocks 1 & 2 & 3 | 18 | 0.86 | 121.41 | 0.56 | 1.00 | |
| BY | Block 1 | 24 | 0.99 | 4.84 | 0.90 | 1.00 |
| Blocks 1 & 2 | 48 | 0.98 | 5.94 | 0.84 | 1.00 | |
| Blocks 1 & 2 & 3 | 72 | 0.98 | 6.07 | 0.83 | 1.00 | |
Internal consistency and test–retest reliability estimates: Issue 4.
| Trial type | Blocks included | T1 α | T2 α | ICC |
|---|---|---|---|---|
| AX | Block 1 | 0.88 | 0.61 | |
| Blocks 1 & 2 | 0.83 | 0.86 | ||
| Blocks 1 & 2 & 3 | 0.88 | 0.91 | ||
| AY | Block 1 | 0.20 | 0.20 | |
| Blocks 1 & 2 | 0.40 | 0.33 | ||
| Blocks 1 & 2 & 3 | 0.44 | 0.66 | ||
| BX | Block 1 | 0.19 | 0.49 | |
| Blocks 1 & 2 | 0.39 | 0.51 | ||
| Blocks 1 & 2 & 3 | 0.56 | 0.68 | ||
| BY | Block 1 | 0.52 | 0.25 | |
| Blocks 1 & 2 | 0.74 | 0.45 | ||
| Blocks 1 & 2 & 3 | 0.79 | 0.56 | ||